Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 9.585M
March 31, 2026 5.594M
December 31, 2025 7.603M
September 30, 2025 9.244M
June 30, 2025 10.11M
March 31, 2025 12.36M
December 31, 2024 7.713M
September 30, 2024 8.307M
June 30, 2024 10.03M
March 31, 2024 8.491M
December 31, 2023 9.520M
September 30, 2023 12.09M
June 30, 2023 11.92M
March 31, 2023 13.46M
December 31, 2022 6.759M
September 30, 2022 9.895M
June 30, 2022 12.25M
March 31, 2022 8.945M
Date Value
December 31, 2021 10.99M
September 30, 2021 15.19M
June 30, 2021 18.03M
March 31, 2021 20.99M
December 31, 2020 5.243M
September 30, 2020 5.950M
June 30, 2020 7.426M
March 31, 2020 5.348M
December 31, 2019 2.836M
September 30, 2019 4.335M
June 30, 2019 4.428M
March 31, 2019 5.456M
December 31, 2018 0.5039M
September 30, 2018 0.76M
June 30, 2018
March 31, 2018
December 31, 2017 1.234M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Johnson & Johnson 201.06B
Eli Lilly & Co. 142.28B

Total Assets (Quarterly) Related Metrics